Accuracy of /sup 99m/Tc-diphosphonate bone scans and roentgenograms in the detection of prostate, breast and lung carcinoma metastases

Conference · Mon Dec 01 04:00:00 EST 1975 · Am. J. Roentgenol., Radium Ther. Nucl. Med., v. 125, no. 4, pp. 972- 977

OSTI ID:4119036

Osmond, III, J D; Pendergrass, H P; Potsaid, M S

A /sup 99m/Tc-diphosphonate scan is a sensitive detector of bony metastases of breast, prostate, and lung cancers. For these particular neoplasms, a negative bone scan in an asymptomatic patient is adequate evidence for absence of bony metastases and a correlative roentgenographic examination may not be necessary. Positive studies demonstrating multiple characteristic discrete areas of increased activity should be considered strong evidence for metastases. Single equivocal lesions require roentgenographic and occasionally biopsy correlation. If roentgenography fails to reveal the source of increased uptake (e.g., degenerative disease) the scan lesion should remain suspicious for metastases. (auth)

• Research Organization: Cape Cod Hospital, Hyannis, MA
• NSA Number: NSA-33-017585
• OSTI ID: 4119036
• Conference Information: Journal Name: Am. J. Roentgenol., Radium Ther. Nucl. Med., v. 125, no. 4, pp. 972- 977
• Country of Publication: United States
• Language: English

Related Subjects

*BONE TISSUES-- SCINTISCANNING
*CARCINOMAS-- DIAGNOSIS
*LUNGS-- CARCINOMAS
*MAMMARY GLANDS-- CARCINOMAS
*METASTASES-- DIAGNOSIS
*PROSTATE-- CARCINOMAS
*SCINTISCANNING-- TECHNETIUM 99
550601* --Biomedical Sciences
Basic Studies--Medicine-- Unsealed Radionuclides in Diagnostics
ISOMERIC NUCLEI
N48830* --Life Sciences--New Tracer Techniques--Other
TRACER TECHNIQUES